These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9207777)

  • 1. Breast cancer genes--what are the real risks?
    Easton D
    Nat Genet; 1997 Jul; 16(3):210-1. PubMed ID: 9207777
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast & ovarian cancer. Issues in risk assessment.
    Caro SW
    Adv Nurse Pract; 1999 Aug; 7(8):26-32; quiz 33-4. PubMed ID: 10745719
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic testing for cancer: a complex decision.
    Harv Womens Health Watch; 2001 Feb; 8(6):2-4. PubMed ID: 11175466
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E
    Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition].
    Ruiz-Flores P; Calderón-Garcidueñas AL; Barrera-Saldaña HA
    Rev Invest Clin; 2001; 53(1):46-64. PubMed ID: 11332051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
    Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
    Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pregnancy and risk of early breast cancer in patients sith BRCA1 and BRCA2 mutations].
    Ost E; Illiger HJ
    Strahlenther Onkol; 2000 Jul; 176(7):335-6. PubMed ID: 10963002
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.
    Díez O; Osorio A; Robledo M; Barroso A; Domènech M; Cortés J; Albertos J; Sanz J; Brunet J; SanRomán JM; Alonso MC; Baiget M; Benítez J
    Br J Cancer; 1999 Mar; 79(7-8):1302-3. PubMed ID: 10098775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary breast cancer.
    Robson ME; Boyd J; Borgen PI; Cody HS
    Curr Probl Surg; 2001 Jun; 38(6):387-480. PubMed ID: 11375625
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic susceptibility to breast and ovarian cancer.
    Skolnick MH; Frank T; Shattuck-Eidens D; Tavtigian S
    Pathol Biol (Paris); 1997 Mar; 45(3):245-9. PubMed ID: 9296070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA: the breast, ovarian, and other cancer genes.
    Boyd J
    Gynecol Oncol; 2001 Mar; 80(3):337-40. PubMed ID: 11263927
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of breast cancer in carriers of BRCA gene mutations.
    Whittemore AS
    N Engl J Med; 1997 Sep; 337(11):788-9. PubMed ID: 9289641
    [No Abstract]   [Full Text] [Related]  

  • 14. Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.
    Fishman A; Dekel E; Chetrit A; Lerner-Geva L; Bar-Am A; Beck D; Beller U; Ben-Baruch G; Piura B; Friedman E; Struewing JP; Modan B
    Gynecol Oncol; 2000 Oct; 79(1):74-8. PubMed ID: 11006035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory identification of hereditary risk of breast and ovarian cancer.
    Frank TS
    Curr Opin Biotechnol; 1999 Jun; 10(3):289-94. PubMed ID: 10361081
    [No Abstract]   [Full Text] [Related]  

  • 16. BRCA1 and BRCA2 mutation carriers as potential candidates for chemoprevention trials.
    Levy-Lahad E; Krieger M; Gottfeld O; Renbaum P; Klein G; Eisenberg S; Lahad A; Kaufman B; Catane R
    J Cell Biochem Suppl; 2000; 34():13-8. PubMed ID: 10762009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetics of breast cancer: can we use today's information?
    Bell NN
    Manag Care Interface; 1998 May; 11(5):52-6. PubMed ID: 10181553
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors associated with decisions about clinical BRCA1/2 testing.
    Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testings for cancer: the surgeon's critical role. Familial breast cancer.
    Weber BL
    J Am Coll Surg; 1999 Jan; 188(1):79-86. PubMed ID: 9915248
    [No Abstract]   [Full Text] [Related]  

  • 20. A common BRCA1 mutation in the Ashkenazim.
    Goldgar DE; Reilly PR
    Nat Genet; 1995 Oct; 11(2):113-4. PubMed ID: 7550331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.